QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 301 filers reported holding QIAGEN NV in Q4 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $938 | -99.8% | 20,424 | +74.9% | 0.09% | +79.2% |
| Q3 2022 | $482,000 | +0.8% | 11,680 | +19.7% | 0.05% | -14.3% |
| Q1 2022 | $478,000 | -64.9% | 9,760 | -60.2% | 0.06% | -62.9% |
| Q4 2021 | $1,361,000 | +81.2% | 24,492 | +57.7% | 0.15% | +98.7% |
| Q2 2021 | $751,000 | -2.2% | 15,530 | -33.3% | 0.08% | -43.7% |
| Q3 2019 | $768,000 | +134.9% | 23,279 | +188.5% | 0.14% | +145.5% |
| Q2 2019 | $327,000 | +31.9% | 8,068 | +11.9% | 0.06% | +27.9% |
| Q4 2018 | $248,000 | -15.9% | 7,210 | -7.4% | 0.04% | +4.9% |
| Q3 2018 | $295,000 | -56.0% | 7,785 | -62.4% | 0.04% | -59.0% |
| Q1 2018 | $670,000 | +110.0% | 20,714 | +100.5% | 0.10% | +75.4% |
| Q4 2017 | $319,000 | +43.7% | 10,330 | +56.3% | 0.06% | +35.7% |
| Q2 2017 | $222,000 | -29.1% | 6,610 | -38.7% | 0.04% | -42.5% |
| Q1 2017 | $313,000 | – | 10,787 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
| Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
| Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
| Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
| SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
| SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
| Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
| Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
| Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |